The Peterson-KFF Health System Tracker provides clear, up-to-date information on trends, drivers and issues that impact the performance of the system. It also illustrates how the U.S. is performing relative to other countries and how different parts of the system are performing relative to one another. A partnership of the Peterson Center on Healthcare and the KFF, the Tracker’s work goal places a heavy emphasis on data and evidence, addressing key questions through collections of charts, which provide data with additional context and synthesis of the latest research and developments. The Tracker also provide regular insight briefs for a more in-depth look at topical questions.
Featured Peterson-KFF Resources
A new chart collection summarizes what is known so far about how health costs and utilization have changed during the pandemic. This builds on a previous analysis exploring the potential cost of treating coronavirus hospitalizations, and a brief explaining the factors driving costs higher or lower and particular considerations for…
Issue Brief See More
Related Peterson-KFF Resources
- How Prepared is the U.S. to Respond to COVID-19 Relative to Other Countries?
- Potential Costs of Coronavirus Treatment for People with Employer Coverage
- How Health Costs Might Change with COVID-19
- Visualizing Health Policy: US Statistics on Surprise Medical Billing
- Surprise Bills Vary by Diagnosis and Type of Admission
- How do healthcare prices and use in the U.S. compare to other countries?
- Health System Dashboard
- Household Health Spending Calculator
- National Health Spending Explorer
- How have healthcare prices grown in the U.S. over time?
- How much is health spending expected to grow?
- What are the recent and forecasted trends in prescription drug spending?
- An analysis of out-of-network claims in large employer health plans
- A Look at How the Opioid Crisis Has Affected People with Employer Coverage
- How Does Cost Affect Access to Care?
The coronavirus outbreak has hit densely populated urban areas of the United States first and hardest. Some health systems have experienced surges of patients, raising concerns that there are not enough hospital beds, staffing, and equipment. The novel coronavirus was slower to spread to rural areas in the U.S., but…
Issue Brief See More
- view as grid
- view as list
Analysis: Cost of Treating Opioid Addiction Rose Rapidly for Large Employers as the Number of Prescriptions Has Declined
A new Kaiser Family Foundation analysis finds that while the use of prescription opioids among people with employer-based health coverage has declined to its lowest levels in over a decade, the cost of treating addiction and overdoses has increased sharply. The annual cost of treating opioid addiction and overdose –…
This Kaiser Family Foundation analysis finds that while prescription opioid use among people with private insurance has declined to its lowest levels in over a decade, the cost of treating opioid abuse has increased substantially.
The Peterson-KFF Health System Tracker provides clear, up-to-date information on trends, drivers and issues that impact the performance of the system. It also illustrates how the U.S. is performing relative to other countries and how different parts of the system are performing relative to one another. A partnership of the Peterson Center on…
A new Kaiser Family Foundation analysis finds about one in four people (24%) covered by large employer plans spent more than $1,000 out-of-pocket on health care in 2015, an increase of seven percentage points from 17 percent in 2005. About 1 in 10 people in such plans (12%) paid…
This Kaiser Family Foundation analysis finds that for workers covered by their employer’s health plans, out-of-pocket costs including deductibles and coinsurance have been increasing significantly faster than costs paid by insurers, reflecting a decade-long trend toward slightly less generous coverage.
Visualizing Health Policy: The Costs and Outcomes of Mental Health and Substance Use Disorders in the US
This Visualizing Health Policy infographic looks at costs and outcomes of mental health and substance use disorders in the United States (US).